Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT

Background: Data are limited regarding the optimal dose and duration of amoxicillin treatment for community-acquired pneumonia in children. Objectives: To determine the efficacy, safety and impact on antimicrobial resistance of shorter (3-day) and longer (7-day) treatment with amoxicillin at both a...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sam Barratt, Julia A Bielicki, David Dunn, Saul N Faust, Adam Finn, Lynda Harper, Pauline Jackson, Mark D Lyttle, Colin VE Powell, Louise Rogers, Damian Roland, Wolfgang Stöhr, Kate Sturgeon, Elia Vitale, Mandy Wan, Diana M Gibb, Mike Sharland
Formato:	article
Lenguaje:	EN
Publicado:	NIHR Journals Library 2021
Materias:	community-acquired pneumonia children amoxicillin antibiotic treatment/duration antibiotic treatment/dose randomised controlled trial Medical technology R855-855.5
Acceso en línea:	https://doaj.org/article/0e90f12c77e941da9612c5c56c0edb52
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT

Ejemplares similares